25 Years of ALTANA Strategy Creates Values
Total Page:16
File Type:pdf, Size:1020Kb
032_Umschlag_GB01_E.qxd 11.04.2002 11:24 Uhr Seite K4 mib25 A - E:Altana:3231_Altana_GB_2001_Englisch:BelDoks_Englisch: Contact Contents 2 Foreword by the Chairman: Strategy creates values 4 The Management Board of ALTANA AG 5 Executive Bodies 6 25 Years: Leading figures of ALTANA 7 Interview with Nikolaus Schweickart 12 ALTANA share: Going for growth 20 Pharmaceuticals: Exploiting creativity This Group Annual Report is also available Dr. Thomas Gauly Financial Calendar 2002 in German. General Representative 34 Chemicals: Overcoming limitations The annual financial statement of ALTANA AG Head of Corporate Communications & Report on Q4 2001 Tuesday, January 29 can be obtained separately (German only): Investor Relations 46 Culture: Promoting dialogue Press Conference on 2001 Annual Results, Bad Homburg Tuesday, March 26 Günther-Quandt-Haus Analysts' Meeting, Frankfurt Tuesday, March 26 56 Management Report fax: +49 6172/404-448 Seedammweg 55 Annual General Meeting, Frankfurt Wednesday, May 8 e-mail: [email protected] D-61352 Bad Homburg v.d.H. 69 Consolidated Financial Statements Report on Q1 2002 / Conference Call Wednesday, May 8 Germany Roadshow United States May 9 – 17 Visit our Web site www.altana.com for up-to-date phone: +49 6172/404-266 109 Major Consolidated Companies Report on Q2 2002 Friday, August 2 news and background information on the fax: +49 6172/404-430 R&D Day Pharmaceuticals Wednesday, September 11 110 Report of the Supervisory Board ALTANA Group. 25 Years of ALTANA Investors' Conference Chemicals Wednesday, October 16 Dr. Elke Krämer 112 Ten-year Review Report on Q3 2002 Wednesday, November 13 Strategy creates values For information on and brochures published by Corporate Publications Autumn Press Conference, Bad Homburg Wednesday, November 13 114 Glossary the Herbert Quandt Foundation please visit: phone: +49 6172/404-393 Analysts' Meeting, Frankfurt Wednesday, November 13 www.h-quandt-stiftung.de fax: +49 6172/404-448 116 Index e-mail: [email protected] · Strategy creates values Back cover: ALTANA The ALTANA Group Worldwide Picture credits: Chronicle: 25 Years of ALTANA Mirko Krizanovic 25 Years of 25 Years Contact Peter Granser (p. 21 and 35) Thomas Rabsch (p. 53, portrait of the artist) Financial Calendar 2002 Jourdan & Müller · PAS (p. 10) Michael Meissen, Frankfurt a. M. (p. 54 and 55) Picture rights: Saskia Niehaus, Cologne VG Bild-Kunst, Bonn, 2001 for the works of Max Beckmann Annual Report 2001 Annual Report 2001 CYAN MAGENTA YELLOW TIEFESILBERBLAUSTANZE CYAN MAGENTA YELLOW TIEFESILBERBLAUSTANZE 032_Umschlag_GB01_E.qxd 11.04.2002 11:24 Uhr Seite K4 mib25 A - E:Altana:3231_Altana_GB_2001_Englisch:BelDoks_Englisch: Contact Contents 2 Foreword by the Chairman: Strategy creates values 4 The Management Board of ALTANA AG 5 Executive Bodies 6 25 Years: Leading figures of ALTANA 7 Interview with Nikolaus Schweickart 12 ALTANA share: Going for growth 20 Pharmaceuticals: Exploiting creativity This Group Annual Report is also available Dr. Thomas Gauly Financial Calendar 2002 in German. General Representative 34 Chemicals: Overcoming limitations The annual financial statement of ALTANA AG Head of Corporate Communications & Report on Q4 2001 Tuesday, January 29 can be obtained separately (German only): Investor Relations 46 Culture: Promoting dialogue Press Conference on 2001 Annual Results, Bad Homburg Tuesday, March 26 Günther-Quandt-Haus Analysts' Meeting, Frankfurt Tuesday, March 26 56 Management Report fax: +49 6172/404-448 Seedammweg 55 Annual General Meeting, Frankfurt Wednesday, May 8 e-mail: [email protected] D-61352 Bad Homburg v.d.H. 69 Consolidated Financial Statements Report on Q1 2002 / Conference Call Wednesday, May 8 Germany Roadshow United States May 9 – 17 Visit our Web site www.altana.com for up-to-date phone: +49 6172/404-266 109 Major Consolidated Companies Report on Q2 2002 Friday, August 2 news and background information on the fax: +49 6172/404-430 R&D Day Pharmaceuticals Wednesday, September 11 110 Report of the Supervisory Board ALTANA Group. 25 Years of ALTANA Investors' Conference Chemicals Wednesday, October 16 Dr. Elke Krämer 112 Ten-year Review Report on Q3 2002 Wednesday, November 13 Strategy creates values For information on and brochures published by Corporate Publications Autumn Press Conference, Bad Homburg Wednesday, November 13 114 Glossary the Herbert Quandt Foundation please visit: phone: +49 6172/404-393 Analysts' Meeting, Frankfurt Wednesday, November 13 www.h-quandt-stiftung.de fax: +49 6172/404-448 116 Index e-mail: [email protected] · Strategy creates values Back cover: ALTANA The ALTANA Group Worldwide Picture credits: Chronicle: 25 Years of ALTANA Mirko Krizanovic 25 Years of 25 Years Contact Peter Granser (p. 21 and 35) Thomas Rabsch (p. 53, portrait of the artist) Financial Calendar 2002 Jourdan & Müller · PAS (p. 10) Michael Meissen, Frankfurt a. M. (p. 54 and 55) Picture rights: Saskia Niehaus, Cologne VG Bild-Kunst, Bonn, 2001 for the works of Max Beckmann Annual Report 2001 Annual Report 2001 CYAN MAGENTA YELLOW TIEFESILBERBLAUSTANZE CYAN MAGENTA YELLOW TIEFESILBERBLAUSTANZE 032_Umschlag_GB01_E.qxd 11.04.2002 11:26 Uhr Seite K2 mib25 A - E:Altana:3231_Altana_GB_2001_Englisch:BelDoks_Englisch: At a glance The new corporate identity The ALTANA Group Worldwide At a glance Asia ALTANA Group 2001 2000* in € million in € million Change in % U.S. and Canada Pharmaceuticals Chemicals Zydus Byk BYK-Chemie Sales 2,308 1,928 +20 Pharmaceuticals Healthcare Ltd. Japan KK Profit before interest, taxes, depreciation and amortization ALTANA Inc. Ahmedabad Osaka (EBITDA) 544 1 396 +38 Melville, N.Y. 50 % ■ ■ 100 % ■ Profit before interest and taxes (EBIT) 439 1 308 +42 100 % ■ ■ Profit before taxes (EBT) 463 1 329 +41 Shunde Rhenacoat Byk Canada Inc. Coating Company Ltd. Return on sales before taxes (in %) 20.1% 1 17.1% Oakville, Ontario Shunde 1,2 Consolidated profit 271 181 +50 100 % ■ 51 % ■ ■ Cash flow from operating activities 348 1 282 +24 Chemicals Tongling Siva Total assets 2,127 1,812 +17 BYK-Chemie USA Insulating Materials Equity 1,187 984 +21 Wallingford, CT Co. Ltd. Equity ratio (in %) 55.8% 54.3% Division of BYK- Chemie USA Inc. Tongling City ■ ■ 100 % ■ ■ 100 % Capital expenditure on property, plant and equipment 171 133 +28 BYK-Gardner Australia Germany Research expenditure 285 219 +30 Columbia, MD Latin America Pharmaceuticals Division of BYK- Pharmaceuticals Chemicals Chemie USA Inc. ALTANA Pharma Number of employees 9,122 8,556 +7 Pharmaceuticals Byk Gulden BYK-Chemie ■ (Pty) Ltd. 100 % Byk Gulden Lomberg Chem. GmbH Africa North Ride Fabrik GmbH Wesel € € S.A. de C.V. Figures per ALTANA share in in Change in % The P.D. George 100 % Mexico City Constance 100 % ■ ■ Pharmaceuticals Dividend 0.60 3 0.44 4 +35 Company Inc. ■ ■ ■ ■ Byk Madaus 100 % 100 % Europe 3 4 5 St. Louis, MO Rhenania Bonus dividend 0.10 0.17 n.c. (Pty) Ltd. ■ ■ 1,2 4 100 % Byk Argentina Oranienburger Coatings GmbH Consolidated profit 1.97 1.30 +51 Midrand Pharmaceuticals Laboratoires Byk Portugal Lda. Chemicals Camattini S.p.A. S.A. Pharmawerk Grevenbroich Cash flow from operating activities 2.53 1 2.03 4 +25 Watson-Rhenania 50 % ■ AB Sangtec Medical Byk France S.A.S. Lisbon Epoxylite UK Ltd. Collechio Buenos Aires GmbH 100 % ■ ■ 1 Excluding special gains from the sale of the stake of the Lundbeck joint venture (€110 million before taxes / €81 million after taxes) and donation to the Herbert Quandt Foundation Coatings-Company Bromma Le Mée-sur-Seine 100 % ■ Bradfort 100 % ■ ■ (€15 million before taxes / €9 million after taxes) 100 % ■ ■ Oranienburg 2 Including special gains from the Lundbeck divestment and donation to the Foundation, consolidated profit totaled €342 million. The earnings per share was €2.49 (+91%) Pittsburgh, PA DS-Chemie 100 % ■ ■ 100 % ■ 100% ■ 3 100 % ■ Byk Roland Salchi- Management recommendation ■ ■ 4 50.1 % Byk Química e GmbH After stock split in 2001 (adjusted to the current share capital) Sangtec Molecular Byk Österreich Polska Sp.z.o.o. Sterling Technology Ltd. Rhenacoat s.r.l. 5 Not comparable (p. 18f.) Farmacêutica Ltda. Roland Arznei- Bremen Diagnostics AB Ges. mbH Warsaw Manchester Milan São Paulo mittel GmbH 100 % ■ ■ Setting the trend – stability and dynamic growth Bromma Vienna 100 % ■ 50.25% ■ ■ 51 % ■ ■ 100 % ■ ■ Hamburg * In the light of ALTANA’s U.S. listing on the New York Stock Exchange planned for ALTANA has received a new logo in order to reflect the major changes the company Joachim Dyes 100 % ■ ■ 100 % ■ 100 % ■ Byk Mazovia BYK-Cera B.V. Syntel S.p.A. May 2002 and the accounting and disclosure regulations stipulated by the U.S. has undergone in recent years. Today ALTANA stands for a focused strategy, financial Lackfabrik GmbH Byk UK Ltd. Byk AG sp.z.o.o. Deventer Quattordio Security and Exchange Commission (SEC), figures referring to certain items in the stability, innovative strength, dynamic growth – and for success. Our new logo Byk Sangtec Lehrte Ely Kreuzlingen Lyskowice 100 % ■ ■ 85 % ■ ■ Diagnostica GmbH 100 % ■ ■ 2000 Consolidated Financial Statements have been adjusted accordingly. For details, underscores the dynamic strength inherent in our stability. From now on it will also 100 % ■ 100% ■ 58% ■ ■ please see p. 78 in the Notes to the Consolidated Financial Statements. Any be the symbol for our activities in the field of pharmaceuticals and chemicals. & Co. KG BYK-Chemie La Artística Wiedeking GmbH Dietzenbach Cambridge Life Byk Gulden Byk Cˇeská France S.A.S. Productos comparisons with the prior year made in this Annual Report refer to the adjusted Kempen 100 % ■ ■ Sciences PLC Italia S.p.A. Republika S.R.O. Le Blanc-Mesnil Químicos S.A. figures in the 2000 Consolidated Financial Statements. 100 % ■ ■ Ely Cormano Prague 100 % ■ Vigo Byk & Diasorin ■ ■ ■ ■ ■ ■ ■ Marketing company Rhenatech GmbH 100 % 100 % 100 % 100 % Diagnostics GmbH Rhenacoat S.A. ■ Manufacturing company Elektro- Dietzenbach Byk Nederland Byk Elmu S.A. Byk Slovakia Montataire DEA TECH isoliersysteme 51% ■ B.V. Madrid S.R.O. 100 % ■ ■ SIVA s.r.l.